These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 1414143)

  • 1. Effects of corticotropin-releasing hormone on the postoperative course of elderly patients under long-term artificial respiration.
    Nink M; Beyer J; Krause U; Holzhauer F; Junginger T; Lehnert H
    Acta Endocrinol (Copenh); 1992 Sep; 127(3):200-4. PubMed ID: 1414143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human corticotropin-releasing hormone in man: dose-response of minute ventilation and end-tidal partial pressures of carbon dioxide and oxygen.
    Oppermann D; Huber I; Nink M; Schulz V
    J Clin Endocrinol Metab; 1987 Feb; 64(2):292-6. PubMed ID: 3098772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of pulsatile human corticotropin-releasing hormone administration on the adrenal insufficiency that follows cure of Cushing's disease.
    Avgerinos PC; Nieman LK; Oldfield EH; Loughlin T; Barnes KM; Loriaux DL; Cutler GB
    J Clin Endocrinol Metab; 1989 May; 68(5):912-6. PubMed ID: 2541160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Studies on the influence of releasing hormones TRH and CRH on respiratory regulation].
    Nink M; Krause U; Lehnert H; Schulz V; Schulz R; Beyer J
    Pneumologie; 1991 May; 45 Suppl 1():246-8. PubMed ID: 1907740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-response effects of exogenous pulsatile human corticotropin-releasing hormone on adrenocorticotropin, cortisol, and gonadotropin concentrations in agonadal women.
    Thomas MA; Rebar RW; LaBarbera AR; Pennington EJ; Liu JH
    J Clin Endocrinol Metab; 1991 Jun; 72(6):1249-54. PubMed ID: 1851183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adrenocorticotropin- and cortisol-releasing effect of hexarelin, a synthetic growth hormone-releasing peptide, in normal subjects and patients with Cushing's syndrome.
    Ghigo E; Arvat E; Ramunni J; Colao A; Gianotti L; Deghenghi R; Lombardi G; Camanni F
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2439-44. PubMed ID: 9253314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dexamethasone does not suppress the respiratory analeptic effect of corticotropin-releasing hormone.
    Huber I; Krause U; Nink M; Lehnert H; Beyer J
    J Clin Endocrinol Metab; 1989 Aug; 69(2):440-2. PubMed ID: 2787801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corticotropin-releasing hormone (CRH) is a respiratory stimulant in humans: a comparative study of human and ovine CRH.
    Nink M; Salomon E; Coutinho M; Treese N; Bernhard G; Krause U; Beyer J; Lehnert H
    Life Sci; 1994; 54(23):1793-9. PubMed ID: 8196493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on facial temperature rise and involvement of serotonin in the respiratory stimulation by CRH.
    Krause U; Nink M; Brauer A; Huber I; Velten A; Lehnert H; Beyer J
    Horm Metab Res; 1991 Oct; 23(10):499-503. PubMed ID: 1761282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hexarelin, a synthetic growth-hormone releasing peptide, shows no interaction with corticotropin-releasing hormone and vasopressin on adrenocorticotropin and cortisol secretion in humans.
    Arvat E; Maccagno B; Ramunni J; Di Vito L; Broglio F; Deghenghi R; Camanni F; Ghigo E
    Neuroendocrinology; 1997 Dec; 66(6):432-8. PubMed ID: 9430449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and side effects of human and ovine corticotropin-releasing hormone administration in man.
    Nink M; Krause U; Lehnert H; Beyer J
    Klin Wochenschr; 1991 Mar; 69(5):185-95. PubMed ID: 2033913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reference ranges and factors affecting the human corticotropin-releasing hormone test in preterm, very low birth weight infants.
    Ng PC; Lam CW; Lee CH; Ma KC; Fok TF; Chan IH; Wong E
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4621-8. PubMed ID: 12364445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulation by peptide histidine methionine (PHM) of adrenocorticotropin secretion in patients with Cushing's disease: a comparison with the effect of vasoactive intestinal peptide (VIP) and a study on the effect of combined administration of corticotropin-releasing hormone with PHM or VIP.
    Watanobe H; Tamura T
    J Clin Endocrinol Metab; 1994 Jun; 78(6):1372-7. PubMed ID: 8200939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulsatile administration of human corticotropin-releasing hormone in patients with secondary adrenal insufficiency: restoration of the normal cortisol secretory pattern.
    Avgerinos PC; Schürmeyer TH; Gold PW; Tomai TP; Loriaux DL; Sherins RJ; Cutler GB; Chrousos GP
    J Clin Endocrinol Metab; 1986 May; 62(5):816-21. PubMed ID: 3007554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychological and endocrine responses to psychosocial stress and dexamethasone/corticotropin-releasing hormone in healthy postmenopausal women and young controls: the impact of age and a two-week estradiol treatment.
    Kudielka BM; Schmidt-Reinwald AK; Hellhammer DH; Kirschbaum C
    Neuroendocrinology; 1999 Dec; 70(6):422-30. PubMed ID: 10657735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The corticotropin-releasing hormone test in normal short children: comparison of plasma adrenocorticotropin and cortisol responses to human corticotropin-releasing hormone and insulin-induced hypoglycemia.
    Goji K
    Acta Endocrinol (Copenh); 1989 Mar; 120(3):390-4. PubMed ID: 2538990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of human corticotropin-releasing hormone on gonadotropin secretion in cycling and postmenopausal women.
    Fischer UG; Wood SH; Bruhn J; Roseff SJ; Mortola J; Rivier JE; Yen SS
    Fertil Steril; 1992 Dec; 58(6):1108-12. PubMed ID: 1459256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of plasma osmolality on pituitary-adrenal responses to corticotropin-releasing hormone and atrial natriuretic peptide changes in central diabetes insipidus.
    Elias LL; Antunes-Rodrigues J; Elias PC; Moreira AC
    J Clin Endocrinol Metab; 1997 Apr; 82(4):1243-7. PubMed ID: 9100602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The hypothalamic-pituitary-adrenal axis in critical illness: response to dexamethasone and corticotropin-releasing hormone.
    Reincke M; Allolio B; Würth G; Winkelmann W
    J Clin Endocrinol Metab; 1993 Jul; 77(1):151-6. PubMed ID: 8392081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human corticotropin-releasing hormone and thyrotropin-releasing hormone modulate the hypercapnic ventilatory response in humans.
    Schulz R; Nink M; Werner GS; Andreas S; Kreuzer H; Beyer J; Lehnert H
    Eur J Clin Invest; 1996 Nov; 26(11):989-95. PubMed ID: 8957205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.